C3 Jian Completes Second Phase 2 Clinical Trial of Anti-Cavity Drug
13 juil. 2015 06h00 HE
|
C3 Jian, Inc.
LOS ANGELES, July 13, 2015 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a biotechnology company focused on reengineering the human microbiome to deliver novel healthcare products, announced it has preliminary...
C3 Jian Advances Knowledge of Human Microbiome
17 juin 2015 19h06 HE
|
C3 Jian, Inc.
LOS ANGELES, June 17, 2015 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on re-engineering the human microbiome to deliver novel healthcare products, announced that its team of...
C3 Jian Adds Two Top Oral Healthcare Professionals to Its Board of Directors
10 nov. 2014 06h00 HE
|
C3 Jian, Inc.
LOS ANGELES, Nov. 10, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare through new pharmaceutical products, announced the appointment of Steven...
C3 Jian Completes Phase 2 Clinical Trial of Anti-Cavity Drug
09 sept. 2014 06h00 HE
|
C3 Jian, Inc.
LOS ANGELES, Sept. 9, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that it has successfully completed the initial Phase 2...
C3 Jian Closes $60M Series D Financing
17 mars 2014 15h12 HE
|
C3 Jian, Inc.
LOS ANGELES, March 17, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on developing proprietary drugs with an initial focus on improving oral healthcare, announced today the close...
C3 Jian Initiates Phase 2 Clinical Trial of Anti-Cavity Drug
07 mars 2014 18h40 HE
|
C3 Jian, Inc.
LOS ANGELES, March 7, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that the first Phase 2 Clinical Trial for its novel drug,...
C3 Jian Successfully Completes Phase 1 Clinical Trial for Dental Caries Product
22 août 2013 13h00 HE
|
C3 Jian, Inc.
LOS ANGELES, Aug. 22, 2013 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a Los Angeles based private biotechnology company focused on providing improved oral healthcare, announced the successful completion of a...
C3 Jian Completes C16G2 Phase 1 Clinical Study Enrollment
19 févr. 2013 14h50 HE
|
C3 Jian, Inc.
LOS ANGELES, Feb. 19, 2013 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the successful completion of Phase 1 study enrollment for its...
C3 Jian Appoints Richard Bastiani to Board of Directors
04 oct. 2012 17h19 HE
|
C3 Jian, Inc.
LOS ANGELES, Oct. 4, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the appointment of Richard Bastiani, Ph.D., as a member of its...
C3 Jian Obtains FDA Acceptance of Investigational New Drug Application
24 mai 2012 12h06 HE
|
C3 Jian, Inc.
LOS ANGELES, May 24, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that its Investigational New Drug Application (IND) for...